Americans are seeking compensation for failed COVID-19 treatments from the Countermeasure Injury Compensation Program (CICP) overseen by the US Department of Health and Human Services (HHS), as reported by Investing.com.
Prior to the pandemic, the program had so far denied compensation in 90% of cases, mostly for H1N1 flu vaccines.
According to a Freedom of Information Act disclosure, 48 claims were filed this year and were pending as of February 16, for serious injuries and deaths from vaccines, ventilators and drugs related to COVID-19.
During a public health emergency, healthcare providers and drug companies can be shielded from almost all lawsuits, and claims for serious injuries or deaths are filed with the CICP. The legal protection extends to COVID-19 vaccines by Moderna, Pfizer, BioNTech, and Johnson & Johnson, as well as approved medicines.
Of the 48 claims related to COVID-19 received by the fund, 21 involved vaccines, including three deaths, according to the FOIA information obtained by Peter Meyers, a law professor and vaccine injury specialist.
Based on the information, it appears fewer than 25 claims were filed in 2020, and it was not clear whether these were COVID-19 related.
To read more NewsPoints articles, click here.